Menu

Trump Picks National Cancer Institute Director

Ned Sharpless currently leads the cancer center at the University of North Carolina, Chapel Hill.

Jun 12, 2017
Kerry Grens

BRIAN STRICKLAND/LINEBERGER COMPREHENSIVE CANCER CENTER Update (October 18): Sharpless was sworn in as NCI director today.

President Donald Trump has selected Ned Sharpless, a physician in charge of the cancer center at the University of North Carolina, Chapel Hill, to lead the National Cancer Institute (NCI). The nomination received praise from the cancer research community.

Margaret Foti, the chief scientific officer of the American Association for Cancer Research, says in a statement she is “absolutely thrilled” by Trump’s choice. “[Sharpless’s] enthusiasm for innovative scientific methods and ideas, as well as his appreciation for the value and importance of basic research to advancing translational discoveries, will allow the NCI to continue leading the way in programs aimed at preventing disease, improving health, and reducing suffering from cancer, while also helping to maintain America’s edge in the life sciences.”

Sharpless’s group studies cellular senescence in aging and cancer. In particular, he researches the role of the tumor suppressor p16INK4a in melanoma.

Since Harold Varmus stepped down as director of the National Cancer Institute in 2015, Douglas Lowy has filled in as acting director. Varmus, whose lab is based at Weill Cornell Medicine, echoes the praise, telling Science: “From everything I know, this is an excellent choice.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.